uridine triphosphate has been researched along with tram 34 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dora, KA; Winter, P | 1 |
| Maniak, PJ; O'Grady, SM; Palmer, ML; Peitzman, ER; Prakash, YS; Sieck, GC | 1 |
| Bouhy, D; David, S; Ghasemlou, N; Lively, S; Rathore, KI; Redensek, A; Schlichter, LC | 1 |
3 other study(ies) available for uridine triphosphate and tram 34
| Article | Year |
|---|---|
Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries.
Topics: Acetylcholine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Apamin; Biological Factors; Blood Flow Velocity; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Mesenteric Artery, Superior; Nitric Oxide; Perfusion; Potassium Channel Blockers; Pressure; Purinergic P2 Receptor Agonists; Pyrazoles; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Small-Conductance Calcium-Activated Potassium Channels; Splanchnic Circulation; Thionucleotides; Uridine Triphosphate; Vasodilation; Vasodilator Agents | 2007 |
K(Ca)3.1 channels facilitate K+ secretion or Na+ absorption depending on apical or basolateral P2Y receptor stimulation.
Topics: Absorption; Adenosine Triphosphate; Apamin; Calcium; Cells, Cultured; Charybdotoxin; Clotrimazole; Egtazic Acid; Epithelial Cells; Humans; Ion Transport; Mammary Glands, Human; Membrane Potentials; Peptides; Potassium; Potassium Channels, Calcium-Activated; Purinergic Agonists; Pyrazoles; Receptors, Purinergic P2Y; Signal Transduction; Sodium; Uridine Triphosphate | 2011 |
Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
Topics: Analysis of Variance; Animals; Animals, Newborn; Calcium; Calcium Signaling; CD11b Antigen; Cells, Cultured; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Intermediate-Conductance Calcium-Activated Potassium Channels; Macrophages; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; Nerve Tissue Proteins; Nitric Oxide Synthase Type II; Potassium Channel Blockers; Pyrazoles; RNA, Messenger; Spinal Cord Injuries; Thapsigargin; Time Factors; Up-Regulation; Uridine Triphosphate | 2011 |